TriSalus Life Sciences, Inc. TLSIW
Nov 2, 2026, 12:32 PM EST
- YTD
- -66.26%
- 1 year
- -56.58%
- Revenue (ttm)
- 24.74M
- Profit margin
- -219.71%
- YTD return
- -66.26%
- 1-year return
- -56.58%
- Volume
- 300
- Avg volume
- 1.73K
- Open
- 1.11
- Previous close
- 0.5601
- Day's range
- 0.56 – 0.65
- 52-week range
- 0.441 – 1.85
- Beta
- 0.50
2Y -0.9500 (-62.91%)
Key statistics
- Enterprise value
- 0
- PEG ratio
- 0.00
- Price / sales
- 0.00
- Price / book
- 0.00
- Dividend yield
- 0.00%
- Payout ratio
- 0.00%
- Revenue growth
- 59.70%
- Free cash flow
- -52.96M
- Total cash
- 16.48M
- Total debt
- 22.76M
- Return on equity
- 0.00%
- Short % of float
- 0.00%
- 50-day average
- 1.21
- 200-day average
- 1.26
Next earnings
Consensus EPS estimate 0.00.
About TriSalus Life Sciences, Inc.
TriSalus Life Sciences, Inc., a medical technology company, researches, develops, and sells drug delivery technologies and immune-oncology therapeutics for the treatment of liver and pancreatic cancer. The company offers Pressure Enabled Drug Delivery infusion systems, such as the TriNav infusion system, which is used in transarterial radioembolization and chemoembolization procedures for patients with liver cancer and metastases; and the Pancreatic Retrograde Venous Infusion device, which is in Phase 1 clinical trial, for locally advanced pancreatic cancer. It also develops nelitolimod, an investigational immunotherapeutic in Phase 1 clinical trial for the treatment of uveal melanoma with liver metastases, hepatocellular carcinoma, intrahepatic cholangiocarcinoma, and locally advanced pancreatic ductal adenocarcinoma. The company serves interventional radiologists, IR technicians, medical oncologists, nursing support, value analysis committee staff, and patients through its sales representatives and sales managers. TriSalus Life Sciences, Inc. was founded in 2009 and is headquartered in Westminster, Colorado.
- Sector
- Healthcare
- Industry
- Medical Devices
- Country
- United States
- Website
- trisaluslifesci.com
News
No recent headlines
Headlines appear here as they are published.
Your note
Sign in to keep a note on TLSIW — it syncs with the Stock Master app.
Institution ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Vestcor Inc | 0.53% | 70,832 | 64.46K | Sep 29, 2024 |
| HRT Financial LP | 0.21% | 28,250 | 25.71K | Sep 29, 2024 |
| B & T Capital Management DBA Alpha Capital Management | 0.17% | 22,222 | 20.22K | Sep 29, 2024 |
| Foster Victor Wealth Advisors, LLC | 0.17% | 22,158 | 20.16K | Sep 29, 2024 |
| Cowen and Company, LLC | 0.15% | 20,369 | 18.54K | Sep 29, 2024 |
| Wolverine Asset Management, LLC | 0.11% | 14,751 | 13.42K | Sep 29, 2024 |
Fund ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Franklin K2 Alternative Strategies Fd | 0.13% | 16,689 | 15.19K | Nov 29, 2023 |